Silvana Romio

1.7k total citations
27 papers, 912 citations indexed

About

Silvana Romio is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Statistics and Probability. According to data from OpenAlex, Silvana Romio has authored 27 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pharmacology and 5 papers in Statistics and Probability. Recurrent topics in Silvana Romio's work include Inflammatory mediators and NSAID effects (6 papers), Statistical Methods in Clinical Trials (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Silvana Romio is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Statistical Methods in Clinical Trials (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Silvana Romio collaborates with scholars based in Netherlands, Italy and United States. Silvana Romio's co-authors include Miriam Sturkenboom, Martijn J. Schuemie, Daniel Weibel, Jan Bonhoeffer, Ron M. C. Herings, Vera E. Valkhoff, Cristina Varas‐Lorenzo, J. Dieleman, K Johansen and Tania Schink and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Silvana Romio

27 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvana Romio Netherlands 14 218 192 139 122 114 27 912
Luisa Ibáñez Spain 21 248 1.1× 171 0.9× 152 1.1× 126 1.0× 68 0.6× 52 1.4k
Annamaria Mascolo Italy 24 160 0.7× 270 1.4× 173 1.2× 94 0.8× 231 2.0× 64 1.2k
Maurizio Sessa Denmark 21 144 0.7× 232 1.2× 273 2.0× 97 0.8× 82 0.7× 96 1.3k
Dan Pettitt United States 13 427 2.0× 242 1.3× 156 1.1× 121 1.0× 119 1.0× 15 1.3k
Victoria Rollason Switzerland 18 176 0.8× 149 0.8× 99 0.7× 65 0.5× 46 0.4× 50 1.3k
Carmen Ferrajolo Italy 24 152 0.7× 89 0.5× 201 1.4× 134 1.1× 139 1.2× 56 1.4k
Julien Bezin France 18 107 0.5× 182 0.9× 155 1.1× 156 1.3× 251 2.2× 67 1.2k
Cyrine E. Haidar United States 19 248 1.1× 99 0.5× 186 1.3× 66 0.5× 103 0.9× 34 2.5k
Jesús Frías Spain 19 228 1.0× 124 0.6× 111 0.8× 102 0.8× 30 0.3× 75 1.3k
Daniel F. B. Wright New Zealand 18 134 0.6× 134 0.7× 156 1.1× 67 0.5× 129 1.1× 73 1.0k

Countries citing papers authored by Silvana Romio

Since Specialization
Citations

This map shows the geographic impact of Silvana Romio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvana Romio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvana Romio more than expected).

Fields of papers citing papers by Silvana Romio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvana Romio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvana Romio. The network helps show where Silvana Romio may publish in the future.

Co-authorship network of co-authors of Silvana Romio

This figure shows the co-authorship network connecting the top 25 collaborators of Silvana Romio. A scholar is included among the top collaborators of Silvana Romio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvana Romio. Silvana Romio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romio, Silvana, Miriam Sturkenboom, & Giovanni Corrao. (2022). Real-world data from the health decision maker perspective. What are we talking about?. SHILAP Revista de lepidopterología. 10(3). 2 indexed citations
2.
Scotti, Lorenza, Silvana Romio, Arianna Ghirardi, et al.. (2022). Should methods of correction for multiple comparisons be applied in pharmacovigilance?. SHILAP Revista de lepidopterología. 12(4). 1 indexed citations
3.
Masclee, Gwen, Huub Straatman, Andrea Arfè, et al.. (2018). Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project. PLoS ONE. 13(11). e0204746–e0204746. 44 indexed citations
4.
Avillach, Paul, Silvana Romio, Erik M. van Mulligen, et al.. (2017). CodeMapper: semiautomatic coding of case definitions. A contribution from the ADVANCE project. Pharmacoepidemiology and Drug Safety. 26(8). 998–1005. 9 indexed citations
5.
Dodd, Caitlin, Maria de Ridder, Silvana Romio, et al.. (2016). Pandemic influenza vaccine & narcolepsy: simulations on the potential impact of bias. Expert Review of Vaccines. 15(5). 573–584. 12 indexed citations
6.
Arfè, Andrea, Lorenza Scotti, Cristina Varas‐Lorenzo, et al.. (2016). Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 354. i4857–i4857. 197 indexed citations
7.
Pérez-Vilar, Silvia, Javier Díez‐Domingo, Joan Puig‐Barberà, Ruth Gil-Prieto, & Silvana Romio. (2015). Intussusception following rotavirus vaccination in the Valencia Region, Spain. Human Vaccines & Immunotherapeutics. 11(7). 1848–1852. 20 indexed citations
8.
Masclee, Gwen, Vera E. Valkhoff, Preciosa M. Coloma, et al.. (2014). Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations. Gastroenterology. 147(4). 784–792.e9. 106 indexed citations
9.
Varas‐Lorenzo, Cristina, Andrea V. Margulis, Manel Pladevall, et al.. (2014). The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies. BMC Cardiovascular Disorders. 14(1). 129–129. 48 indexed citations
10.
11.
Trifirò, Gianluca, Preciosa M. Coloma, Peter R. Rijnbeek, et al.. (2014). Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?. Journal of Internal Medicine. 275(6). 551–561. 87 indexed citations
12.
Verhamme, Katia, et al.. (2013). Chronic kidney disease as effect modifier in the association between the use of tiotropium respimat and mortality. European Respiratory Journal. 42(Suppl 57). 4632–4632. 1 indexed citations
13.
14.
Verhamme, Katia, Robert Zietse, Loes E. Visser, et al.. (2013). Overanticoagulation is associated with renal function decline. Journal of Nephrology. 26(4). 691–698. 6 indexed citations
15.
Verhamme, Katia, et al.. (2013). Use of tiotropium Respimat Soft Mist InhalerversusHandiHaler and mortality in patients with COPD. European Respiratory Journal. 42(3). 606–615. 44 indexed citations
16.
Lucchi, S, Bianca Kollhorst, Tania Schink, et al.. (2012). Risk of upper gastrointestinal complications associated with use of individual non-steroidal anti-inflammatory drugs in the SOS Project.. Pharmacoepidemiology and Drug Safety. 21. 2 indexed citations
17.
Ruiter, Rikje, Loes E. Visser, Myrthe P. P. van Herk‐Sukel, et al.. (2012). Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals. Drug Safety. 35(6). 471–480. 33 indexed citations
18.
Dodd, Caitlin, Héctor S. Izurieta, Patrick Zuber, et al.. (2012). International Collaborative Case Series Safety Monitoring for Pandemic 2009 H1N1 Vaccines: Estimation of the Risk of Guillain-Barre Syndrome. Data Archiving and Networked Services (DANS). 21. 361–362. 1 indexed citations
19.
Dieleman, J., Silvana Romio, K Johansen, et al.. (2011). Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ. 343(jul12 2). d3908–d3908. 129 indexed citations
20.
Corrao, Giovanni, Silvana Romio, Antonella Zambon, et al.. (2010). Multiple outcomes associated with the use of metformin and sulphonylureas in type 2 diabetes: a population-based cohort study in Italy. European Journal of Clinical Pharmacology. 67(3). 289–299. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Ibáñez Breakdown of academic impact, for papers by Annamaria Mascolo Breakdown of academic impact, for papers by Maurizio Sessa Breakdown of academic impact, for papers by Dan Pettitt Breakdown of academic impact, for papers by Victoria Rollason Breakdown of academic impact, for papers by Carmen Ferrajolo Breakdown of academic impact, for papers by Julien Bezin Breakdown of academic impact, for papers by Cyrine E. Haidar Breakdown of academic impact, for papers by Jesús Frías Breakdown of academic impact, for papers by Daniel F. B. Wright
Rankless by CCL
2026